3 Results for "

EGFR-IN-26

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "EGFR-IN-26" in MCE Product Catalog:

Cat. No.: HY-142518
CAS No.: 2375470-64-5
Target:  

VEGFR

Research Areas:  

Cancer

EGFR-IN-26 is a EGFR inhibitor extracted from patent WO2019162323A1 compound I-028. EGFR-IN-26 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-159101
Target:  

EGFR PD-1/PD-L1

Research Areas:  

Cancer

EP26 is a potent and orally active EGFR and PD-L1 inhibitor with IC50 values of 48.6 nM, 1.77 µM, respectively. EP26 decreased the protein expression of p-EGFR. EP26 induces cell cycle arrest at G0/G1 phase. EP26 has the potential for the research of glioblastoma .
loading...
    loading...
Cat. No.: HY-181766
EGFR/VEGFR2-IN-11 is an EGFR/VEGFR2 inhibitor with IC50 values of 0.62 μM (human EGFR), 2.26 μM (human VEGFR-2), 17.38 μM (human COX-2), and 19.31 μM (human tubulin). EGFR/VEGFR2-IN-11 inhibits COX-2 activity and tubulin polymerization. EGFR/VEGFR2-IN-11 induces cell cycle arrest and apoptosis. EGFR/VEGFR2-IN-11 exerts selective and antiproliferative activity against human cancer cells. EGFR/VEGFR2-IN-11 can be used for the research of colon carcinoma, breast carcinoma, leukemia, lymphoma, glioblastoma .
loading...
    loading...